• Product NameBetahistine
• Brief DescriptionInhibitors
• Purification99.87%
• Biological ActivityBetahistine is a histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers. Betahistine dihydrochloride is an anti-vertigo drug. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms associated with Mnire's disease. It was first registered in Europe in 1970 for the treatment of Mnire's disease
• Target NameHistamine Receptor inhibitor
• CAS No. 5638-76-6
• Calculated MW 136.19
• Formulation C8H12N2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Otitis
  SMILES:CNCCC1=NC=CC=C1
  Pathways:GPCR/G Protein; Immunology/Inflammation; Neuroscience
  Receptor:H1 receptor
  Boling pt:
  Melting pt:
  Solubility:Soluble in DMSO, not in water
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1.Albu S,et al . Treatment of Meniere's disease with intratympanic dexamethazone plus high dosage of betahistine. Am J Otolaryngol. 2016 May-Jun;37(3):225-30.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting